Tech Company Financing Transactions
Neuble AI Funding Round
Neuble AI, based in Seoul, secured $269 thousand in investment from FuturePlay and private investors.
Transaction Overview
Company Name
Announced On
7/16/2026
Transaction Type
Venture Equity
Amount
$269,000
Round
Seed
Investors
FuturePlay (Lead Investor)
Proceeds Purpose
The newly raised capital will support regulatory submissions to South Korea's Ministry of Food and Drug Safety (MFDS), the U.S. Food and Drug Administration (FDA), and the European CE marking process ahead of BrainCura's commercial launch.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
3F, 188 Dogok-ro, Gangnam-gu A03
Seoul, 06255
Republic of Korea
Seoul, 06255
Republic of Korea
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Neuble is a medical AI solutions company dedicated to overcoming the limitations of conventional imaging systems and setting new standards for human health through artificial intelligence. Going beyond simple image analysis, Neuble uncovers the hidden value within data to provide patients with rapid diagnoses and clinicians with evidence-based diagnostic confidence. Neuble is pioneering the future of accessible precision medicine, starting from the closest point of care.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sung Ahn
Browse more venture capital transactions:
Prev: 7/16/2026: Sable venture capital transaction
Next: 7/16/2026: Alpaca venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. All VC database entries on this site are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs